Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Glimepiride
Trade Name
Amaryl
Manufacturer
Aventis Pharma
Risk Category
C
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • Oral hypoglycemic agent of sulfonylurea group.
  • Fetal Risk
    Fetal Risk
  • Use isn’t recommended during pregnancy.
  • Risk of prolonged neonatal hypoglycemia in neonates of mothers who received sulfonylurea antenatally.
  • Risk of intruterine fetal death.
  • Breast Feeding
    Breast Feeding
  • Unknown excretion in human milk.
  • Not recommended for use in nursing mothers because of the potential to cause neontal hypoglycemia and reported adverse effects in animals.
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     10   +   5    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year